Difference between revisions of "Template:Eicosanoids"
Jump to navigation
Jump to search
imported>Frietjes |
imported>Glycong m (fix typos) |
||
| (9 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| name = Eicosanoids | | name = Eicosanoids | ||
| − | | title = | + | | title = [[Eicosanoid]]s |
| bodyclass = hlist | | bodyclass = hlist | ||
| Line 11: | Line 11: | ||
| list2 = | | list2 = | ||
{{Navbox|subgroup | {{Navbox|subgroup | ||
| − | | group1 = [[Prostaglandin]]s (PG) | + | | group1 = [[Prostaglandin]]s (PG) |
| list1 = | | list1 = | ||
{{Navbox|subgroup | {{Navbox|subgroup | ||
| Line 27: | Line 27: | ||
| group2 = [[Prostaglandin E|E]]/F | | group2 = [[Prostaglandin E|E]]/F | ||
| list2 = | | list2 = | ||
| − | * [[Prostaglandin E2|E<sub>2</sub> (Dinoprostone) | + | * [[Prostaglandin E2|E<sub>2</sub> (Dinoprostone)]] |
| − | |||
| − | * [[Prostaglandin E1|E<sub>1</sub> (Alprostadil) | + | * [[Prostaglandin E1|E<sub>1</sub> (Alprostadil)]] |
| − | |||
| − | * [[Prostaglandin F2alpha|F<sub>2α</sub> (Dinoprost)]]: | + | * [[Prostaglandin F2alpha|F<sub>2α</sub> (Dinoprost)]]: |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| group3 = I | | group3 = I | ||
| list3 = | | list3 = | ||
| − | * [[Prostacyclin|I<sub>2</sub> (Prostacyclin/Epoprostenol)]]: | + | * [[Prostacyclin|I<sub>2</sub> (Prostacyclin/Epoprostenol)]]: |
| − | |||
| − | |||
}} | }} | ||
| Line 75: | Line 66: | ||
}} | }} | ||
| − | | group4 = [[Nonclassic eicosanoid|Nonclassic]] | + | | group4 = [[Eoxin]]s (EX) |
| − | | | + | | list4 = {{Navbox|subgroup |
| − | * [[Lipoxin]]s ([[Lipoxin|A<sub>4</sub>]], [[Lipoxin|B<sub>4</sub>]]) | + | | group1 = Precursor |
| + | | list1 = | ||
| + | * [[Arachidonic acid 15-hydroperoxide]] | ||
| + | |||
| + | | group2 = Eoxins | ||
| + | | list2 = | ||
| + | * [[Eoxin A4|A<sub>4</sub>]] | ||
| + | * [[Eoxin C4|C<sub>4</sub>]] | ||
| + | * [[Eoxin D4|D<sub>4</sub>]] | ||
| + | * [[Eoxin E4|E<sub>4</sub>]] | ||
| + | }} | ||
| + | |||
| + | | group5 = [[Nonclassic eicosanoid|Nonclassic]] | ||
| + | | list5 = | ||
| + | * [[Lipoxin]]s (LX) ([[Lipoxin|A<sub>4</sub>]], [[Lipoxin|B<sub>4</sub>]]) | ||
* [[Virodhamine]] | * [[Virodhamine]] | ||
| − | | | + | | group6 = By function |
| − | | | + | | list6 = |
* ''[[bronchoconstriction]]'' | * ''[[bronchoconstriction]]'' | ||
| Line 93: | Line 98: | ||
** [[Prostaglandin F2alpha|PGF<sub>2α</sub>]] | ** [[Prostaglandin F2alpha|PGF<sub>2α</sub>]] | ||
** [[Thromboxane A2|TXA<sub>2</sub>]] | ** [[Thromboxane A2|TXA<sub>2</sub>]] | ||
| − | ** [[Thromboxane B2|TXB<sub>2</sub>]] | + | ** [[Thromboxane B2|TXB<sub>2</sub>]] |
* ''[[vasodilation]]'' | * ''[[vasodilation]]'' | ||
** [[Prostaglandin E2|PGE<sub>2</sub>]] | ** [[Prostaglandin E2|PGE<sub>2</sub>]] | ||
| Line 120: | Line 125: | ||
** [[Prostaglandin F2alpha|PGF<sub>2α</sub>]] (Dinoprost) | ** [[Prostaglandin F2alpha|PGF<sub>2α</sub>]] (Dinoprost) | ||
| − | + | ||
| − | |||
}}<noinclude> | }}<noinclude> | ||
| − | |||
[[Category:Lipid metabolic pathway templates]] | [[Category:Lipid metabolic pathway templates]] | ||
</noinclude> | </noinclude> | ||